Skip to content

R&D at other companies

Avalo Therapeutics logo
Avalo TherapeuticsAVTX
$14.05M+54.0%
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
$42.12M+1.6%
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
$73M+38.7%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
$35.68M+17.1%
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
$98.16M+22.3%
Alumis Inc. logo
Alumis Inc.ALMS
$81.54M-15.6%

Segments

By segment

See full
Viaskin Peanut Segment$11.4M+7.5%

By product

See full
Expenses by function$8.5M+84.8%

Other financials

Income statement

See full
Revenue$900.0K+12.5%
Operating income-$47.9M-80.1%
Net income-$47.6M-75.6%
EPS (diluted)-$0.11+57.7%

Balance sheet

See full
Cash & equivalents$229.2M+1,668%
Total debt$6.1M-15.7%
Total equity$207.9M+7,069%
Total assets$266.4M+427%

Cash flow

See full
Operating cash flow-$49.1M-149%
CapEx$400.0K
Free cash flow-$49.5M-151%

Valuation

See full
Market cap$948.17M+269%
Enterprise value$725.07M+188%
P/S163.9×+91.4×

Profitability

See full
Operating margin-2,910.4%-265pp
Net margin-2,895.4%-257pp
FCF margin-2,619.5%+69.9pp

Returns & leverage

See full
Return on equity-158.9%-26.4pp
Debt / equity-2.5×
Current ratio4.8×+4.0×

Where this comes from

Reported directly by DBV Technologies in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: DBV Technologies’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about DBV Technologies's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is DBV Technologies's R&D?
DBV Technologies (DBVT) reported R&D of $33.4M in Q1 2026.
How has DBV Technologies's R&D changed year-over-year?
DBV Technologies's R&D increased by 55.3% year-over-year, from $21.5M to $33.4M.
What is the long-term trend for DBV Technologies's R&D?
Over 4 years (2021 to 2025), DBV Technologies's R&D has grown at a 13.5% compound annual growth rate (CAGR), from $70.34M to $116.7M.
What does R&D mean?
Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.